Skip to main content

Table 1 General characteristics of the participants

From: Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients

age

52.4 ± 10.0

Men/Women (%)

94/48 (66.2/33.8)

duration of DM(year)

6.1 ± 5.0

Body mass index (kg/m2)

24.6 ± 3.7

Systolic BP (mmHg)

127.8 ± 14.7

Diastolic BP (mmHg)

78.1 ± 8.6

HbA1C (%)

7.9 ± 1.9 (5.5-16.2)

FPG (mg/dL)

141 (73-377)

eGFR (mL/min/1.73 m2)

80.6 ± 16.0

Total cholesterol (mg/dL)

168.6 ± 32.0

LDL-cholesterol (mg/dL)

95.2 ± 27.7

Hypertension, n (%)

46 (32.1)

HDL-cholesterol (mg/dL)

47.7 ± 15.2

Triglycerides (mg/dL)

126 (38-1013)

hsCRP (mg/dL)

0.08 (0.03-11.42)

apolipoprotein B (mg/dL)

78.2 ± 22.3

ABI

1.11 ± 0.12

PWV (cm/sec)

1515 ± 248

HOMA-IR

2.69 (0.09-29.01)

smoking, n (%)

47(33.1)

Alcohol, n (%)

62 (43.7)

treatment modality no medication, n (%)

32 (22.7)

OHA, n (%)

97 (68.8)

OHA + Insulin, n (%)

5 (3.5)

Insulin, n (%)

7 (5.0)

  1. Data are shown as mean ± SD, median (minimum-maximum) or as n (%).
  2. FPG: fasting plasma glucose; eGFR: estimated glomerular filtration rate;
  3. LDL: Low density lipoprotein; HDL: high density lipoprotein;
  4. hsCRP: high-sensitivity C-reactive protein; ABI: ankle-brachial index;
  5. PWV: pulse wave velocity; HOMA-IR: Homeostasis model assessment-insulin resistance;
  6. OHA: oral hypoglycemic agent